Financials ACI Formulations Limited

Equities

ACIFORMULA

BD0480ACIFL4

Agricultural Chemicals

End-of-day quote Dhaka S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
122.2 BDT -0.65% Intraday chart for ACI Formulations Limited -1.61% -21.16%

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 7,366 6,858 4,959 6,669 7,470 7,380
Enterprise Value (EV) 1 10,014 8,513 6,424 8,148 9,945 9,979
P/E ratio 62.8 x 52.6 x 53.5 x 31.2 x 30.8 x 31.4 x
Yield 2.14% 2.3% 1.81% 2.02% 1.58% 1.6%
Capitalization / Revenue 1.77 x 1.69 x 1.45 x 1.73 x 1.76 x 1.49 x
EV / Revenue 2.41 x 2.1 x 1.88 x 2.11 x 2.34 x 2.01 x
EV / EBITDA 24.9 x 17.8 x 15.7 x 17.5 x 20.1 x 17.8 x
EV / FCF -12.9 x 7.48 x 18 x 157 x -11 x -269 x
FCF Yield -7.72% 13.4% 5.57% 0.64% -9.07% -0.37%
Price to Book 2.95 x 2.78 x 2.06 x 2.22 x 2.4 x 2.42 x
Nbr of stocks (in thousands) 47,250 47,250 47,250 47,250 47,250 47,250
Reference price 2 155.9 145.1 105.0 141.1 158.1 156.2
Announcement Date 8/29/18 10/24/19 10/28/20 12/13/21 12/13/22 10/26/23
1BDT in Million2BDT
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 4,153 4,052 3,424 3,865 4,247 4,960
EBITDA 1 401.4 477.7 409.8 464.8 495.7 560.8
EBIT 1 337.8 409.3 344.3 417.8 454.4 514.8
Operating Margin 8.13% 10.1% 10.06% 10.81% 10.7% 10.38%
Earnings before Tax (EBT) 1 166.3 184.3 126.2 290.9 328.8 312
Net income 1 117.2 130.3 92.73 213.5 242.9 234.9
Net margin 2.82% 3.22% 2.71% 5.52% 5.72% 4.74%
EPS 2 2.481 2.758 1.963 4.518 5.140 4.970
Free Cash Flow 1 -773.6 1,138 357.8 52.04 -902.1 -37.04
FCF margin -18.63% 28.09% 10.45% 1.35% -21.24% -0.75%
FCF Conversion (EBITDA) - 238.27% 87.31% 11.2% - -
FCF Conversion (Net income) - 873.35% 385.84% 24.38% - -
Dividend per Share 2 3.333 3.333 1.905 2.857 2.500 2.500
Announcement Date 8/29/18 10/24/19 10/28/20 12/13/21 12/13/22 10/26/23
1BDT in Million2BDT
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 2,648 1,655 1,465 1,479 2,475 2,599
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 6.596 x 3.465 x 3.576 x 3.183 x 4.992 x 4.634 x
Free Cash Flow 1 -774 1,138 358 52 -902 -37
ROE (net income / shareholders' equity) 4.75% 5.25% 3.81% 7.9% 7.94% 7.62%
ROA (Net income/ Total Assets) 3.77% 4.11% 3.73% 4.68% 4.68% 4.9%
Assets 1 3,111 3,170 2,486 4,561 5,187 4,798
Book Value Per Share 2 52.80 52.20 50.80 63.60 65.90 64.60
Cash Flow per Share 2 5.550 6.320 5.280 4.060 4.750 4.190
Capex 1 63.8 219 23.6 11.1 30.3 112
Capex / Sales 1.54% 5.4% 0.69% 0.29% 0.71% 2.26%
Announcement Date 8/29/18 10/24/19 10/28/20 12/13/21 12/13/22 10/26/23
1BDT in Million2BDT
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. ACIFORMULA Stock
  4. Financials ACI Formulations Limited